Fulgent Genetics
Combines hereditary-cancer and pathology testing with a nanoencapsulated cancer-drug pipeline in clinical trials.
$19.61
After-hours close−0.01 (−0.05%)
At close$19.62(−1.65%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.65 | — | — |
| Jul 2026 | −$0.46 | −$0.58 | −26.1% |
| May 2026 | −$0.35 | −$0.36 | −3.4% |
| Feb 2026 | $0.03 | $0.16 | +433.3% |
| Nov 2025 | −$0.24 | $0.14 | +158.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | −$0.65 | — | — | $86.3M | — | — |
| Jul 30, 2026 | −$0.46 | −$0.58 | −26.1% | $94.0M | $85.4M | −9.2% |
| May 1, 2026 | −$0.35 | −$0.36 | −3.4% | $68.1M | $71.1M | +4.5% |
| Feb 27, 2026 | $0.03 | $0.16 | +433.3% | $85.4M | $83.3M | −2.4% |
| Nov 7, 2025 | −$0.24 | $0.14 | +158.3% | $85.4M | $84.1M | −1.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 1, 2025 | ||||||
| May 2, 2025 | ||||||
| Feb 28, 2025 | ||||||
| Nov 8, 2024 | ||||||
| Aug 2, 2024 | ||||||
| May 3, 2024 | ||||||
| Feb 28, 2024 | ||||||
| Nov 3, 2023 | ||||||
| Aug 4, 2023 | ||||||
| May 5, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 7, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 3, 2022 | ||||||
| Feb 23, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 6, 2021 | ||||||
| Mar 4, 2021 | ||||||
| Nov 9, 2020 | ||||||
| Aug 4, 2020 | ||||||
| May 4, 2020 | ||||||
| Mar 10, 2020 | ||||||
| Nov 4, 2019 | ||||||
| Aug 5, 2019 | ||||||
| May 7, 2019 | ||||||
| Feb 28, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 6, 2018 | ||||||
| May 7, 2018 | ||||||
| Feb 28, 2018 | ||||||
| Nov 6, 2017 | ||||||
| Aug 7, 2017 | ||||||
| May 8, 2017 | ||||||
| Feb 27, 2017 | ||||||
| Nov 14, 2016 | ||||||
| Sep 29, 2016 | ||||||
| Mar 31, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Sep 30, 2015 | ||||||
| Jun 30, 2015 | ||||||